Covestor LTD Quest Diagnostics Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Covestor LTD holds 1,825 shares of DGX stock, worth $250,189. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,825

Previous 1,890 3.44%

Holding current value

$250,189

Previous $259,000 9.27%

% of portfolio

0.18%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$137.09 - $137.09 $8,910 - $8,910	-65 Reduced 3.44%	1,825 $283,000
Q2 2024 Aug 09, 2024	SELL	$125.91 - $144.34 $16,746 - $19,197	-133 Reduced 6.57%	1,890 $259,000
Q1 2024 May 10, 2024	BUY	$123.78 - $142.11 $13,120 - $15,063	106 Added 5.53%	2,023 $269,000
Q4 2023 Feb 09, 2024	BUY	$120.62 - $141.12 $10,855 - $12,700	90 Added 4.93%	1,917 $265,000
Q3 2023 Nov 13, 2023	BUY	$121.86 - $144.92 $22,178 - $26,375	182 Added 11.06%	1,827 $223,000
Q2 2023 Aug 11, 2023	BUY	$130.56 - $146.84 $1,958 - $2,202	15 Added 0.92%	1,645 $231,000
Q1 2023 May 15, 2023	SELL	$131.53 - $155.76 $11,443 - $13,551	-87 Reduced 5.07%	1,630 $230,000
Q4 2022 Feb 13, 2023	SELL	$123.31 - $157.26 $8,878 - $11,322	-72 Reduced 4.02%	1,717 $268,000
Q3 2022 Nov 14, 2022	SELL	$121.77 - $141.1 $11,202 - $12,981	-92 Reduced 4.89%	1,789 $219,000
Q2 2022 Aug 10, 2022	SELL	$127.07 - $145.39 $3,303 - $3,780	-26 Reduced 1.36%	1,881 $250,000
Q1 2022 May 13, 2022	BUY	$129.09 - $164.35 $110,630 - $140,847	857 Added 81.62%	1,907 $261,000
Q4 2021 Feb 10, 2022	BUY	$140.36 - $173.01 $147,378 - $181,660	1,050 New	1,050 $182,000

Others Institutions Holding DGX

# of Institutions

923

Shares Held

95M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account